摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-(4-phenylpiperazin-1-yl)butyl)-N-propyl-1,4-dioxaspiro[4.5]decan-8-amine | 1026083-85-1

中文名称
——
中文别名
——
英文名称
N-(4-(4-phenylpiperazin-1-yl)butyl)-N-propyl-1,4-dioxaspiro[4.5]decan-8-amine
英文别名
——
N-(4-(4-phenylpiperazin-1-yl)butyl)-N-propyl-1,4-dioxaspiro[4.5]decan-8-amine化学式
CAS
1026083-85-1
化学式
C25H41N3O2
mdl
——
分子量
415.619
InChiKey
LSTOMPCHATUCNE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.99
  • 重原子数:
    30.0
  • 可旋转键数:
    9.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.76
  • 拓扑面积:
    28.18
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    N-(4-(4-phenylpiperazin-1-yl)butyl)-N-propyl-1,4-dioxaspiro[4.5]decan-8-amine盐酸 作用下, 以 四氢呋喃 为溶剂, 反应 6.0h, 以80%的产率得到4-((4-(4-phenylpiperazin-1-yl)butyl)(propyl)amino)cyclohexanone
    参考文献:
    名称:
    Bioisosteric Heterocyclic Versions of 7-{[2-(4-Phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: Identification of Highly Potent and Selective Agonists for Dopamine D3 Receptor with Potent in Vivo Activity
    摘要:
    In the current report, we extend the SAR study on our hybrid structure 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol further to include heterocyclic bioisosteric analogues. Binding assays were carried out with HEK-293 cells expressing either D2 or D3 receptors with tritiated spiperone to evaluate inhibition constants (K). Functional activity of selected compounds in stimulating GTP gamma S binding was assessed with CHO cells expressing human D2 receptors and AtT-20 cells expressing human D3 receptors. The highest binding affinity and selectivity for D3 receptors were exhibited by (-)-34 (K-i = 0.92 nM and D2/D3 = 253). In the functional GTP gamma S binding assay, (-)-34 exhibited full agonist activity with picomolar affinity for D3 receptor with high selectivity (EC50 = 0.08 nM and D2/D3 = 248). In the in vivo rotational study, (-)-34 exhibited potent rotational activity in 6-OH-DA unilaterally lesioned rats with long duration of action, which indicates its potential application in neuroprotective treatment of Parkinson's disease.
    DOI:
    10.1021/jm701524h
  • 作为产物:
    描述:
    N-(4-(4-phenylpiperazin-1-yl)butyl)-1,4-dioxaspiro[4.5]decan-8-amine溴丙烷potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 10.0h, 以60%的产率得到N-(4-(4-phenylpiperazin-1-yl)butyl)-N-propyl-1,4-dioxaspiro[4.5]decan-8-amine
    参考文献:
    名称:
    Bioisosteric Heterocyclic Versions of 7-{[2-(4-Phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: Identification of Highly Potent and Selective Agonists for Dopamine D3 Receptor with Potent in Vivo Activity
    摘要:
    In the current report, we extend the SAR study on our hybrid structure 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol further to include heterocyclic bioisosteric analogues. Binding assays were carried out with HEK-293 cells expressing either D2 or D3 receptors with tritiated spiperone to evaluate inhibition constants (K). Functional activity of selected compounds in stimulating GTP gamma S binding was assessed with CHO cells expressing human D2 receptors and AtT-20 cells expressing human D3 receptors. The highest binding affinity and selectivity for D3 receptors were exhibited by (-)-34 (K-i = 0.92 nM and D2/D3 = 253). In the functional GTP gamma S binding assay, (-)-34 exhibited full agonist activity with picomolar affinity for D3 receptor with high selectivity (EC50 = 0.08 nM and D2/D3 = 248). In the in vivo rotational study, (-)-34 exhibited potent rotational activity in 6-OH-DA unilaterally lesioned rats with long duration of action, which indicates its potential application in neuroprotective treatment of Parkinson's disease.
    DOI:
    10.1021/jm701524h
点击查看最新优质反应信息